GENE ONLINE|News &
Opinion
Blog

2022-01-07| Asia-Pacific

GeneOnline’s Top 10 Hong Kong Biotech IPOs of 2021

by GeneOnline
Share To
Hong Kong is Asia’s largest and the world’s second-largest destination for biotech companies wanting to go public. Amidst the backdrop of COVID-19 and changes in the political and regulatory environment in 2021, companies have forged on to make a splash on the HKEX. Here are 10 of them, ranked by the size of their IPOs. 

GO Prime with only $1.49 now

SUBSCRIBE NOW
LATEST
Study Finds Treatment Variations in Immunobullous Disorders Linked to Demographic Factors
2026-01-24
Study Finds Orexin Receptor Agonists May Pose Higher Fracture Risk Compared to Melatonin Receptor Agonists
2026-01-24
Researchers Develop Distributed Method Using Control Barrier Functions to Enhance Network Connectivity
2026-01-24
Study by Khamsai et al. Links Community Living Factors to Dementia Risk in Older Adults
2026-01-24
Researchers Use CFD Simulations to Optimize Ejector Design for Improved Hydrogen Recirculation in PEM Fuel Cells
2026-01-24
Researchers Develop Pre-Trained Models to Enhance Robotic Navigation in Complex Terrains
2026-01-24
3D Printing Technology Enhances Patient Education Through Physical Models in Healthcare
2026-01-24
READ MORE
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-10
Bioprocessing Summit Europe (Biomanufacturing Trends)
Barcelona, Spain
2026-03-23
29th European Biotechnology Congress (Biotech R&D)
Rome, Italy
SEE MORE
Scroll to Top